Review of European guidelines for economic evaluation of medical technologies and pharmaceuticals J.-M. Graf von der SchulenburgC. Hoffmann Guest Editorial Pages: 2 - 8
Validity of willingness-to-pay for nondecisional diagnostic information J.L. SeverensTh.D. de BooG.J. van der Wilt Original Papers Pages: 9 - 13
Cost of schizophrenia studies: a methodological review Fabrizio TediosiFabio ParazziniLivio Garattini Original Papers Pages: 14 - 19
The cost structure of illness due to hepatitis A in Germany R. DielB. Rappenhöner Original Papers Pages: 20 - 25
Burden of illness imposed by osteoporosis in Germany J.G. BrechtP.K. Schädlich Invited Papers Pages: 26 - 32
Healthcare applications of decision analytic modeling J. BellseyA.M. Sheldon Invited Papers Pages: 37 - 43
Pharmaceutical Pricing and Reimbursement in the United Kingdom D. Macarthur Pricing and Reimbursement Systems in Europe Pages: 47 - 50
Preisfestsetzung und Erstattung von Arzneimitteln in Großbritannien D. Macarthur Pricing and Reimbursement Systems in Europe Pages: 50 - 55
The institutional and procedural reform of approval of medical devices for reimbursement in France F. Giraudet Pricing and Reimbursement Systems in Europe Pages: 56 - 62
La réforme institutionelle et procédurale de l'admission des dispositifs médicaux au remboursement en France F. Giraudet Pricing and Reimbursement Systems in Europe Pages: 63 - 69
Aktuelle Gesundheitspolitik in Deutschland P. Marx Pricing and Reimbursement Systems in Europe Pages: 72 - 73
